Quantitation of 5-fluorouracil (5-FU) in human plasma by liquid chromatography/electrospray ionization tandem mass spectrometry

Rapid Communications in Mass Spectrometry

Volumn 22, Issue 2, 2008, Pages 224-230

  Kosovec, Juliann E ^a   Egorin, Merrill J ^a,b   Gjurich, Susanna ^a   Beumer, Jan H ^a,c  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG PRODUCTS; ELECTROSPRAY IONIZATION; HYDROPHILICITY; LIQUID CHROMATOGRAPHY; PATIENT MONITORING; PLASMA (HUMAN); PLASMA STABILITY;

5-FLUOROURACIL; ELECTROSPRAY IONIZATION TANDEM MASS SPECTROMETRY; HUMAN PLASMAS; HYDROPHILIC INTERACTION CHROMATOGRAPHY; ISOTOPICALLY LABELED; LIQUID CHROMATOGRAPHY ELECTROSPRAY; LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY; PLASMA CONCENTRATION; THERAPEUTIC DRUG MONITORING; TOXICITY BALANCE;

MASS SPECTROMETRY;

EID: 38549101556     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.3362     Document Type: Article

References (35)

1. Longley DB, Harkin DP, Johnston PG. Nat. Rev. Cancer 2003; 3: 330.
2. Malet-Martino M, Jolimaitre P, Martino R. Curr. Med. Chem. Anticancer Agents 2002; 2: 267.
3. Kaestner SA, Sewell GJ. Clin. Oncol. (Royal College of Radiologists (Great Britain)) 2007; 19: 23.
4. Lindman H, Astrom G, Ahlgren J, Villman K, Blomqvist C, Nygren P, Bergh J. Acta Oncologica 2007; 46: 165.
5. Gamelin E, Boisdron-Celle M, Guerin-Meyer V, Delva R, Lortholary A, Genevieve F, Larra F, Ifrah N, Robert J. J. Clin. Oncol. 1999; 17: 1105.
6. Highlights from: 5-Fluorouracil Drug Management Pharmacokinetics and Pharmacogenomics Workshop, Orlando, Florida, January 2007. Clin. Colorectal Cancer 2007; 6: 407.
7. Gamelin E, Boisdron-Celle M, Delva R, Regimbeau C, Cailleux PE, Alleaume C, Maillet ML, Goudier MJ, Sire M, Person-Joly MC, Maigre M, Maillart P, Fety R, Burtin P, Lortholary A, Dumesnil Y, Picon L, Geslin J, Gesta P, Danquechin-Dorval E, Larra F, Robert J. J. Clin. Oncol. 1998; 16: 1470.
8. Escoriaza J, Aldaz A, Calvo E, Giraldez J. J. Chromatogr. B 1999; 736: 97.
9. Gamelin EC, Danquechin-Dorval EM, Dumesnil YF, Maillart PJ, Goudier MJ, Burtin PC, Delva RG, Lortholary AH, Gesta PH, Larra FG. Cancer 1996; 77: 441.
10. Di Paolo A, Danesi R, Ciofi L, Vannozzi F, Bocci G, Lastella M, Amatori F, Martelloni BM, Ibrahim T, Amadori D, Falcone A, Del Tacca M. Therap. Drug Monit. 2005; 27: 362.
11. Sabatini L, Barbieri A, Tosi M, Violante FS. J. Mass Spectrom. 2005; 40: 669.
12. Matsushima E, Yoshida K, Kitamura R, Yoshida K. J. Chromatogr. B 1997; 691: 95.
13. Wung WE, Howell SB. Clin. Chem. 1980; 26: 1704.
14. Iwamoto M, Yoshida S, Hirose S. J. Chromatogr. 1984; 310: 151.
15. Compagnon P, Thiberville L, Moore N, Thuillez C, Lacroix C. J. Chromatogr. B 1996; 677: 380.
16. Maeda T, Sumi S, Hayashi K, Kidouchi K, Owaki T, Togari H, Fujimoto S, Wada Y. J. Chromatogr. B 1999; 731: 267.
17. Siethoff C, Orth M, Ortling A, Brendel E, Wagner-Redeker W. J. Mass Spectrom. 2004; 39: 884.
18. Pisano R, Breda M, Grassi S, James CA. J. Pharmaceut. Biomed. Anal. 2005; 38: 738.
19. Dhananjeyan MR, Liu J, Bykowski C, Trendel JA, Sarver JG, Ando H, Erhardt PW. J. Chromatogr. A 2007; 1138: 101.
20. Bocci G, Danesi R, Di Paolo AD, Innocenti F, Allegrini G, Falcone A, Melosi A, Battistoni M, Barsanti G, Conte PF, Del Tacca M. Clin. Cancer Res. 2000; 6: 3032.
21. Maring JG, Schouten L, Greijdanus B, de Vries EG, Uges DR. Therap. Drug Monit. 2005; 27: 25.
22. Bates CD, Watson DG, Willmott N, Logan H, Goldberg J. J. Pharmaceut. Biomed. Anal. 1991; 9: 19.
23. De Leenheer AP, Cosyns-Duyck MC. J. Pharmaceut. Sci. 1979; 68: 1174.
24. Wu AT, Schwandt HJ, Finn C, Sadee W. Res. Commun. Chem. Pathol. Pharmacol. 1976; 14: 89.
25. de Bruin EA, Tjaden UR, van Oosterom AT, Leeflang P, Leclercq PA. J. Chromatog. 1983; 279: 603.
26. Gastavsson B, Almersjo O, Berne M, Waldenstrom J. J. Chromatogr. 1983; 276: 395.
27. Joulia JM, Pinguet F, Grosse PY, Astre C, Bressolle F. J. Chromatogr. B 1997; 692: 427.
28. Remaud G, Boisdron-Celle M, Morel A, Gamelin A. J. Chromatogr. B 2005; 824: 153.
29. Van Kuilenburg AB, van Lenthe H, Maring JG, Van Gennip AH. Nucleosides Nucleotides Nucleic Acids 2006; 25: 1257.
30. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM) Guidance for Industry - Bioanalytical Method Validation, 1-5-2001. Available: http://www.fda.gov/cder/guidance/4252fnl.pdf.
31. Rosing H, Man WY, Doyle E, Bult A, Beijnen JH. J. Liq. Chromatogr. Related Technol. 2000; 23: 329.
32. Beumer JH, Eiseman JL, Parise RA, Joseph E, Holleran JL, Covey JM, Egorin MJ. Clin. Cancer Res. 2006; 12: 7483.
33. Beumer JH, Parise RA, Newman EM, Doroshow JH, Synold TW, Lenz H, Egorin MJ. Cancer Chemother. Pharmacol. 2007; in press.
34. Olsen BA. Journal of chromatography. A 2001; 913: 113.
35. Hemstrom P, Irgum K. J. Sep. Sci. 2006; 29: 1784.